Longtime Minnesota-based generic drugmaker Upsher-Smith Laboratories, which was sold to a Taiwanese firm in 2024, is closing one of its two drug plants in the state and refocusing work here on the ...

The outlook and technical action suggest Abbott Laboratories (NYSE: ABT) will lead healthcare names like Johnson & Johnson (NYSE: JNJ) higher in 2025. While each produced a solid quarter ...

Abbott Laboratories (NYSE:ABT) reported its Q3 2024 earnings, meeting EPS expectations while slightly missing revenue forecasts. The company posted an EPS of $1.34, aligning with analysts' predictions ...

Police in Plymouth say they are searching for a suspect following a "serious assault" in the West Hoe area of the city. Devon and Cornwall Police said its officers were called at 20:55 GMT on ...

Good morning and thank you for standing by. Welcome to Abbott’s Fourth Quarter 2024 Earnings Conference Call. All participants will be able to listen only until the question-and-answer portion ...

In this article, we are going to take a look at where Abbott Laboratories (NYSE:ABT) stands against other stocks expected to post impressive earnings this week. The earnings season is in full flow ...

Members of the public were last night warned to "stay away" from part of Plymouth due to a huge police operation. Photos shared on social media show several emergency service vehicles swarm on ...

Abbott Laboratories expects first quarter 2025 adjusted EPS of $1.05-$1.09 versus consensus of $1.11. Price Action: ABT stock is up 0.72% at $117.64 at the last check Wednesday.

On Wednesday, Abbott Laboratories (NYSE:ABT) reported fourth-quarter sales of $10.97 billion, up 7.2% year over year, missing the consensus of $11.01 billion. Organic sales growth for the underlying ...

Jan 22 (Reuters) - Abbott Laboratories (ABT.N), opens new tab on Wednesday forecast 2025 profit that came in line with Wall Street estimates as it expects new device launches and growing demand ...